Recall of Diabetes Medication Due To Harmful Cancer Causing Substance

People take medication because it is necessary to cure or manage an illness.  What happens when the medication has an unintended consequence?

Viona Pharmaceuticals, a New Jersey based pharmaceutical company is recalling all 33 lots of its type 2 diabetes drug 750 mg strength metformin.  This product is used to improve blood glucose control in adults with type 2 diabetes mellitus. The recall has occurred after long-term testing revealed too much NDMA, which is classified as a probable human carcinogen and was the reason for numerous metformin recalls in 2020. Specifically, this is a substance that could result in cancer.

Lots being recalled include, but are not limited to:

Nos. M008130-133, exp. date 06/2022; M010080-81, exp. 07/2022; M011029-32, exp. 08/2022; M013394-96, M013966-67, exp. 09/2022; M100831-32, exp. 12/2022; M100833-34, M101267, M102718-20, exp. 01/2023; M102721-22, M104172-76, exp. 02/2023; M105889-90, exp. 03/2023.

The attorneys at Finkelstein, Blankinship, Frei-Pearson & Garber, LLP have successfully represented consumers in similar matters.  If you have purchased or know someone who has purchased Viona Pharmaceutical’s Metformin Hydrochloride Extended-Release Tablets and were harmed by the product, contact us to discuss your legal options.